Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Methylglyoxal Modified Proteins anticorps

Cet anticorps anti-Methylglyoxal Modified Proteins Monoclonal Souris (Clone MGO-1) (ABIN1108230) détecte spécifiquement Methylglyoxal Modified Proteins dans IHC (p), WB et EIA. L’anticorps est réactif avec des échantillons de Différentes espèces.
N° du produit ABIN1108230
969,23 €
Plus frais de livraison 40,00 € et TVA
0.1 mg
Destination: France
Envoi sous 17 jours ouvrables

Aperçu rapide pour Methylglyoxal Modified Proteins anticorps (ABIN1108230)

Antigène

Methylglyoxal Modified Proteins

Reactivité

Différentes espèces

Hôte

  • 1
Souris

Clonalité

  • 1
Monoclonal

Conjugué

  • 1
Inconjugué

Application

Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB), Enzyme Immunoassay (EIA)

Clone

MGO-1
  • Réactivité croisée (Details)

    Species reactivity (tested):Human. Multispecies cross reactant.

    Purification

    Protein G

    Immunogène

    MGO-modified KLH

    Isotype

    IgG1
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    0.1 mg/mL

    Buffer

    PBS, 0.02 % sodium azide, 0.1 % bovine serum albumin

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Store at 2 - 8 °C.
  • Antigène

    Methylglyoxal Modified Proteins

    Sujet

    Methylglyoxal (MGO) is an endogenous product of glucose metabolism. Increased production and accumulation of methylglyoxal (MGO), as well as increased modification of proteins by glycoxidation, are hallmarks of aging and diabetes. MGO was shown to modify proteins and to contribute to the accumulation of damaged proteins that can be toxic to cells. A number of studies have shown that MGO levels are significantly elevated in patients with Type 2 Diabetes and correlates well with fasting plasma glucose and hemoglobin A1c (HbA1c) levels. Moreover, increased formation of the MGO is implicated in renal dysfunction and is known to be involved in the development of DN (diabetic nephropathy).
Vous êtes ici:
Chat with us!